APO Research
Talk to an analyst

APO RESEARCH · REPORT

Emicizumab Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Emicizumab Injection Market Outlook and Growth Opportunities 2026

27 December 2025198 pages

Choose your research edition.

Industry ResearchEmicizumab Injection Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Emicizumab Injection Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Emicizumab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Emicizumab Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Emicizumab Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Emicizumab Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Emicizumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Emicizumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Emicizumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Emicizumab Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Emicizumab Injection market include Roche Pharma (Schweiz) AG and Chugai Pharmaceutical among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Emicizumab Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Emicizumab Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Emicizumab Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Emicizumab Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Emicizumab Injection Segment by Company

Roche Pharma (Schweiz) AG

Chugai Pharmaceutical

Emicizumab Injection Segment by Type

60mg (0.4ml)/Bottle

30mg (1ml)/Bottle

150mg (1ml)/Bottle

105mg (0.7ml)/Bottle

Emicizumab Injection Segment by Application

Hospital

Clinic

Others

Emicizumab Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Emicizumab Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Emicizumab Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Emicizumab Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Emicizumab Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Emicizumab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Emicizumab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Emicizumab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Emicizumab Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Emicizumab Injection industry.

Chapter 3: Detailed analysis of Emicizumab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Emicizumab Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Emicizumab Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Emicizumab Injection Industry Trends Table 2. Emicizumab Injection Industry Drivers Table 3. Emicizumab Injection Industry Opportunities and Challenges Table 4. Emicizumab Injection Industry Restraints Table 5. Global Emicizumab Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Emicizumab Injection Revenue Share by Company (2021-2026) Table 7. Global Emicizumab Injection Sales Volume by Company (L) & (2021-2026) Table 8. Global Emicizumab Injection Sales Volume Share by Company (2021-2026) Table 9. Global Emicizumab Injection Average Price (US$/mL) of Company (2021-2026) Table 10. Global Emicizumab Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Emicizumab Injection Key Company Manufacturing Base & Headquarters Table 12. Global Emicizumab Injection Company, Product Type & Application Table 13. Global Emicizumab Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Emicizumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 60mg (0.4ml)/Bottle Table 18. Significant Companies of 30mg (1ml)/Bottle Table 19. Significant Companies of 150mg (1ml)/Bottle Table 20. Significant Companies of 105mg (0.7ml)/Bottle Table 21. Global Emicizumab Injection Sales Volume by Type 2021 VS 2025 VS 2032 (L) Table 22. Global Emicizumab Injection Sales Volume by Type (2021-2026) & (L) Table 23. Global Emicizumab Injection Sales Volume by Type (2027-2032) & (L) Table 24. Global Emicizumab Injection Sales Volume Share by Type (2021-2026) Table 25. Global Emicizumab Injection Sales Volume Share by Type (2027-2032) Table 26. Global Emicizumab Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Emicizumab Injection Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Emicizumab Injection Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Emicizumab Injection Sales Value Share by Type (2021-2026) Table 30. Global Emicizumab Injection Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Clinic Table 33. Significant Companies of Others Table 34. Global Emicizumab Injection Sales Volume by Application 2021 VS 2025 VS 2032 (L) Table 35. Global Emicizumab Injection Sales Volume by Application (2021-2026) & (L) Table 36. Global Emicizumab Injection Sales Volume by Application (2027-2032) & (L) Table 37. Global Emicizumab Injection Sales Volume Share by Application (2021-2026) Table 38. Global Emicizumab Injection Sales Volume Share by Application (2027-2032) Table 39. Global Emicizumab Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Emicizumab Injection Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Emicizumab Injection Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Emicizumab Injection Sales Value Share by Application (2021-2026) Table 43. Global Emicizumab Injection Sales Value Share by Application (2027-2032) Table 44. Global Emicizumab Injection Sales by Region: 2021 VS 2025 VS 2032 (L) Table 45. Global Emicizumab Injection Sales by Region (2021-2026) & (L) Table 46. Global Emicizumab Injection Sales Market Share by Region (2021-2026) Table 47. Global Emicizumab Injection Sales by Region (2027-2032) & (L) Table 48. Global Emicizumab Injection Sales Market Share by Region (2027-2032) Table 49. Global Emicizumab Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Emicizumab Injection Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Emicizumab Injection Sales Value Share by Region (2021-2026) Table 52. Global Emicizumab Injection Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Emicizumab Injection Sales Value Share by Region (2027-2032) Table 54. Global Emicizumab Injection Market Average Price (US$/mL) by Region (2021-2026) Table 55. Global Emicizumab Injection Market Average Price (US$/mL) by Region (2027-2032) Table 56. Global Emicizumab Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Table 57. Global Emicizumab Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Emicizumab Injection Sales by Country (2021-2026) & (L) Table 59. Global Emicizumab Injection Sales Market Share by Country (2021-2026) Table 60. Global Emicizumab Injection Sales by Country (2027-2032) & (L) Table 61. Global Emicizumab Injection Sales Market Share by Country (2027-2032) Table 62. Global Emicizumab Injection Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Emicizumab Injection Sales Value Market Share by Country (2021-2026) Table 64. Global Emicizumab Injection Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Emicizumab Injection Sales Value Market Share by Country (2027-2032) Table 66. Roche Pharma (Schweiz) AG Company Information Table 67. Roche Pharma (Schweiz) AG Business Overview Table 68. Roche Pharma (Schweiz) AG Emicizumab Injection Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 69. Roche Pharma (Schweiz) AG Emicizumab Injection Product Portfolio Table 70. Roche Pharma (Schweiz) AG Recent Development Table 71. Chugai Pharmaceutical Company Information Table 72. Chugai Pharmaceutical Business Overview Table 73. Chugai Pharmaceutical Emicizumab Injection Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 74. Chugai Pharmaceutical Emicizumab Injection Product Portfolio Table 75. Chugai Pharmaceutical Recent Development Table 76. Key Raw Materials Table 77. Raw Materials Key Suppliers Table 78. Emicizumab Injection Distributors List Table 79. Emicizumab Injection Customers List Table 80. Research Programs/Design for This Report Table 81. Authors List of This Report Table 82. Secondary Sources Table 83. Primary Sources List of Figures Figure 1. Emicizumab Injection Product Image Figure 2. Global Emicizumab Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Emicizumab Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Emicizumab Injection Sales (2021-2032) & (L) Figure 5. Global Emicizumab Injection Sales Average Price (US$/mL) & (2021-2032) Figure 6. Global Emicizumab Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 60mg (0.4ml)/Bottle Image Figure 10. 30mg (1ml)/Bottle Image Figure 11. 150mg (1ml)/Bottle Image Figure 12. 105mg (0.7ml)/Bottle Image Figure 13. Global Emicizumab Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (L) Figure 14. Global Emicizumab Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Emicizumab Injection Sales Volume Share by Type (2021-2032) Figure 16. Global Emicizumab Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Emicizumab Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Emicizumab Injection Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Emicizumab Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (L) Figure 23. Global Emicizumab Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Emicizumab Injection Sales Volume Share by Application (2021-2032) Figure 25. Global Emicizumab Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Emicizumab Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Emicizumab Injection Sales Value Share by Application (2021-2032) Figure 28. Global Emicizumab Injection Sales by Region: 2021 VS 2025 VS 2032 (L) Figure 29. Global Emicizumab Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Emicizumab Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Emicizumab Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Emicizumab Injection Sales Value (2021-2032) & (US$ Million) Figure 33. North America Emicizumab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Emicizumab Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Emicizumab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Emicizumab Injection Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Emicizumab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Emicizumab Injection Sales Value (2021-2032) & (US$ Million) Figure 39. South America Emicizumab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Emicizumab Injection Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Emicizumab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Emicizumab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Emicizumab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Emicizumab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Emicizumab Injection Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Emicizumab Injection Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 60mg (0.4ml)/Bottle
  • 30mg (1ml)/Bottle
  • 150mg (1ml)/Bottle
  • 105mg (0.7ml)/Bottle
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Roche Pharma (Schweiz) AG
  • Chugai Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Emicizumab Injection Sales Value (2021-2032)
  4. 1.2.2 Global Emicizumab Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Emicizumab Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Emicizumab Injection Market Dynamics
  1. 2.1 Emicizumab Injection Industry Trends
  2. 2.2 Emicizumab Injection Industry Drivers
  3. 2.3 Emicizumab Injection Industry Opportunities and Challenges
  4. 2.4 Emicizumab Injection Industry Restraints
3 Emicizumab Injection Market by Company
  1. 3.1 Global Emicizumab Injection Company Revenue Ranking in 2025
  2. 3.2 Global Emicizumab Injection Revenue by Company (2021-2026)
  3. 3.3 Global Emicizumab Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Emicizumab Injection Average Price by Company (2021-2026)
  5. 3.5 Global Emicizumab Injection Company Ranking (2024-2026)
  6. 3.6 Global Emicizumab Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Emicizumab Injection Company Product Type and Application
  8. 3.8 Global Emicizumab Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Emicizumab Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Emicizumab Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Emicizumab Injection Market by Type
  1. 4.1 Emicizumab Injection Type Introduction
  2. 4.1.1 60mg (0.4ml)/Bottle
  3. 4.1.2 30mg (1ml)/Bottle
  4. 4.1.3 150mg (1ml)/Bottle
  5. 4.1.4 105mg (0.7ml)/Bottle
  6. 4.2 Global Emicizumab Injection Sales Volume by Type
  7. 4.2.1 Global Emicizumab Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Emicizumab Injection Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Emicizumab Injection Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Emicizumab Injection Sales Value by Type
  11. 4.3.1 Global Emicizumab Injection Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Emicizumab Injection Sales Value by Type (2021-2032)
  13. 4.3.3 Global Emicizumab Injection Sales Value Share by Type (2021-2032)
5 Emicizumab Injection Market by Application
  1. 5.1 Emicizumab Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Emicizumab Injection Sales Volume by Application
  6. 5.2.1 Global Emicizumab Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Emicizumab Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Emicizumab Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Emicizumab Injection Sales Value by Application
  10. 5.3.1 Global Emicizumab Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Emicizumab Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Emicizumab Injection Sales Value Share by Application (2021-2032)
6 Emicizumab Injection Regional Sales and Value Analysis
  1. 6.1 Global Emicizumab Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Emicizumab Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Emicizumab Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Emicizumab Injection Sales by Region (2027-2032)
  5. 6.3 Global Emicizumab Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Emicizumab Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Emicizumab Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Emicizumab Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Emicizumab Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Emicizumab Injection Sales Value (2021-2032)
  12. 6.6.2 North America Emicizumab Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Emicizumab Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Emicizumab Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Emicizumab Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Emicizumab Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Emicizumab Injection Sales Value (2021-2032)
  21. 6.9.2 South America Emicizumab Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Emicizumab Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Emicizumab Injection Sales Value Share by Country, 2025 VS 2032
7 Emicizumab Injection Country-level Sales and Value Analysis
  1. 7.1 Global Emicizumab Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Emicizumab Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Emicizumab Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Emicizumab Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Emicizumab Injection Sales by Country (2027-2032)
  6. 7.4 Global Emicizumab Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Emicizumab Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Emicizumab Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Emicizumab Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Emicizumab Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Emicizumab Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Emicizumab Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Emicizumab Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Emicizumab Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Emicizumab Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Emicizumab Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Emicizumab Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Emicizumab Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Emicizumab Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Emicizumab Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Emicizumab Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Emicizumab Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Emicizumab Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Emicizumab Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Emicizumab Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Emicizumab Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Emicizumab Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Emicizumab Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Emicizumab Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Emicizumab Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Emicizumab Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Emicizumab Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Emicizumab Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Emicizumab Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Emicizumab Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Emicizumab Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Emicizumab Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Emicizumab Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche Pharma (Schweiz) AG
  2. 8.1.1 Roche Pharma (Schweiz) AG Company Information
  3. 8.1.2 Roche Pharma (Schweiz) AG Business Overview
  4. 8.1.3 Roche Pharma (Schweiz) AG Emicizumab Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Roche Pharma (Schweiz) AG Emicizumab Injection Product Portfolio
  6. 8.1.5 Roche Pharma (Schweiz) AG Recent Developments
  7. 8.2 Chugai Pharmaceutical
  8. 8.2.1 Chugai Pharmaceutical Company Information
  9. 8.2.2 Chugai Pharmaceutical Business Overview
  10. 8.2.3 Chugai Pharmaceutical Emicizumab Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Chugai Pharmaceutical Emicizumab Injection Product Portfolio
  12. 8.2.5 Chugai Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Emicizumab Injection Value Chain Analysis
  2. 9.1.1 Emicizumab Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Emicizumab Injection Sales Mode & Process
  6. 9.2 Emicizumab Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Emicizumab Injection Distributors
  9. 9.2.3 Emicizumab Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst